Published on 24 Feb 2024 on Simply Wall St. via Yahoo Finance
The investors in Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) will be rubbing their hands together with glee today, after the share price leapt 57% to US$8.36 in the week following its yearly results. The results don't look great, especially considering that statutory losses grew 873% toUS$0.90 per share. Revenues of US$289m did beat expectations by 3.5%, but it looks like a bit of a cold comfort. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
View our latest analysis for Maravai LifeSciences Holdings
earnings-and-revenue-growth